Hemodialysis is a process that uses artificial membrane to remove
waste, such as urea, from the blood, restore proper balance of
electrolytes in the blood, and eliminate extra fluid from the body.
When kidney function goes below 10% to 15%, it is no longer able to
filter blood. This causes toxins to build up in the body along with
excess fluid. Hemodialysis is used to remove these toxins. It is an
effective treatment for those with end stage renal disease. There are
different types of hemodialysis. In-center hemodialysis is performed
in hospitals or dialysis centers. Home hemodialysis is done at home
three days a week in presence of a technician. Daily home
hemodialysis is done at home five to seven days a week. Nocturnal
home hemodialysis is done overnight in six to eight hours.
Report Overview @
https://www.transparencymarketresearch.com/hemodialysis-market.html
According to the National Kidney Foundation, 10% of the global
population is affected by chronic kidney disease (CKD). Over 2
million people currently receive treatment with dialysis or a kidney
transplant. Of these 2 million people receive treatment for kidney
failure, the majority are treated in only five countries: the U.S.,
Japan, Germany, Brazil, and Italy. These five countries represent
only 12% of the world’s population. Only 20% are treated in about
100 developing countries which make up over 50% of the world’s
population. According to 2010 Global Burden of Disease study, chronic
kidney disease was ranked 27th in the list of causes of total number
of deaths worldwide in 1990, but rose to 18th in 2010. According to
the National Institute of Diabetes and Digestive and Kidney Diseases
Health Information Center, over 661,000 people in the U.S. have
kidney failure. Of these, 468,000 individuals are on dialysis, and
roughly 193,000 live with a functioning kidney transplant. In 2013,
88.2% of patients began renal replacement therapy with hemodialysis,
9.0% started with peritoneal dialysis, and 2.6% received preemptive
kidney transplant. As of 2013, 63.7% of all ESRD patients were
receiving hemodialysis therapy, 6.8% were being treated with
peritoneal dialysis, and 29.2% had a functioning kidney transplant.
The hemodialysis market can be segmented into hemodialysis products,
consumables, and hemodialysis services. Increasing incidence of
kidney failure and chronic renal dysfunction is expected to propel
the hemodialysis market during the forecast period. Additionally,
growing awareness about hemodialysis devices and services is
anticipated to generate high demand for hemodialysis treatment
globally during the forecast period.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30347
Based on product type, the hemodialysis market has been segmented
into dialyzers and hemodialysis machines. Based on services, the
hemodialysis market has been segmented into in-center hemodialysis
services and home hemodialysis services.
In terms of region, the global hemodialysis market has been segmented
into North America, Europe, Asia Pacific, Latin America, and Middle
East & Africa. The U.S. is considered the world’s largest
market for hemodialysis products, followed by Europe. Japan has
become the third largest hemodialysis market in Asia. Collaboration
between product manufacturers and service providers is augmenting the
hemodialysis market. Fresenius Medical Care AG & Co. KGaA
announced the opening of eight new centers in collaboration with John
Hopkins Hospital in 2017. These centers would be located in
Baltimore, the U.S., to meet the rising demand in the region.
The focus of manufacturers is on the shift from the use of
no-tunneled dialysis catheters to tunneled cuffed dialysis catheters
in the recent past for vascular access. These catheters are suggested
for short and intermediate use. Major players in the hemodialysis
market are Baxter International, B. Braun Medical Ltd., DaVita, Inc.,
Fresenius Medical Care AG & Co. KGaA, Toray Industries, Inc.,
Nikkiso Co. Ltd., JMS Co. Ltd., and Gambro, among others.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=30347<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment